Pilot Study of Posaconazole in Crohn's Disease
Stopped Recruitment challenges; changes in manufacturing
Conditions
- Crohn Disease
- CARD9 S12N Risk Allele
Interventions
- DRUG: Posaconazole Delayed Release Oral Tablet
- DRUG: Matching Placebo Tablet
Sponsor
Cedars-Sinai Medical Center
Collaborators